Menu

The Eye

An overview of visual processing

Oct 1, 2014
The Scientist Staff

See full infographic: JPG | PDF© THOM GRAVESAs light penetrates the eye, the cornea refracts the light through the pupil and then the lens, which focuses the light onto the retina. There, photosensitive cells initiate electrical signals that travel along the optic nerve carrying the visual information to various brain areas in the opposite hemisphere, including the lateral geniculate nucleus (LGN), which relays the sensory information to the visual cortex at the back of the brain.

To reach the photoreceptors—the rods and cones—at the back of the retina, light must first travel through a thicket of other retinal cells. Glial cells called Müller cells guide incoming light to the photoreceptors, where photons are translated into nerve impulses via a biochemical reaction mediated by photopigments in the membrane of the cells’ outer segments. Bipolar neurons relay the signal from the photoreceptors to the ganglion cells, whose axons form the optic nerve, with the help of amacrine and horizontal neuronal cells.

See full infographic: JPG | PDF

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.